The Potential Role of Cellular Senescence in Non-Alcoholic Fatty Liver Disease
Open accessThe DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Abstract
Non-alcoholic fatty liver disease (NAFLD) represents an increasing global health burden. Cellular senescence develops in response to cellular injury, leading not only to cell cycle arrest but also to alterations of the cellular phenotype and metabolic functions. In this review, we critically discuss the currently existing evidence for the involvement of cellular senescence in NAFLD in order to identify areas requiring further exploration. Hepatocyte senescence can be a central pathomechanism as it may foster intracellular fat accumulation, fibrosis and inflammation, also due to secretion of senescence-associated inflammatory mediators. However, in some non-parenchymal liver cell types, such as hepatic stellate cells, senescence may be beneficial by reducing the extracellular matrix deposition and thereby reducing fibrosis. Deciphering the detailed interaction between NAFLD and cellular senescence will be essential to discover novel therapeutic targets halting disease progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Disease progression in fatty liver disease. Obesity and metabolic disorders represent risk factors for NAFLD, which starts with fat accumulation in hepatocytes. Further disease progression is characterized by inflammation (NASH) and subsequent fibrogenesis leading to cirrhosis. NASH with and without cirrhosis bears the risk of developing hepatocellular carcinoma (HCC) [5,6,20].](https://figures.cochat.ai/paper-figures/23d01315a94e420ca4374747008d0181/the-potential-role-of-cellular-senescence-in-non-alcoholic-fatty-liver-disease-figure-1.jpg)
![Figure 2 Mechanisms of cellular senescence. Cellular senescence can have various triggers such as telomere shortening, DNA damage, oncogene activation and mitochondria-related factors such as reactive oxygen species (ROS) and mitochondrial DNA damage. Upon injury, the DNA damage response (DDR) mechanisms are activated and signal transduction through protein phosphorylation of ATM, ATR, CHKs stabilizes p53, thus inducing cell cycle arrest through RB. Senescence cells show high expression of p16 and p21 and high activity of SA-β-gal and secrete cytokines and chemoattractants via SASP (modified from Di Micco R et al. [30]).](https://figures.cochat.ai/paper-figures/ed7d67bcdfc94bc79bbe9dd77c47374a/the-potential-role-of-cellular-senescence-in-non-alcoholic-fatty-liver-disease-figure-2.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, driven by signalling pathways such as NOTCH1, SASP cells contribute to a pro-inflammatory microenvironment by secreting inflammatory cytokines, growth factors and matrix-degrading enzymes which have been implicated in the progression of NASH.45,46”
From Understanding the cellular interactome of non-alcoholic fatty liver disease (2022) · cites this paper as [45]
Experimental — accuracy not yet measuredIn the citing paper
“Key responses of hepatocytes to metabolic injury include the activation of inflammatory and pro-apoptotic signalling, e.g. via tumour necrosis factor (TNF)α and NF-κB,3 favouring hepatocyte cell death pathways and/or senescence.16,17”
From An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH (2023) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
Eslam, M., Newsome, P. N., Sarin, S. K., Anstee, Q. M., Targher, G., Romero-Gomez, M., Zelber-Sagi, S., Wai-Sun Wong, V., Dufour, J.-F., Schattenberg, J. M., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.03.039 · Cited by 4,472
Mechanisms of NAFLD development and therapeutic strategies
Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M., & Sanyal, A. J. (2018) · Nature Medicine · doi:10.1038/s41591-018-0104-9 · Cited by 4,354
Cellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
Marchesini, G., Bugianesi, E., Forlani, G., Cerrelli, F., Lenzi, M., Manini, R., Natale, S., Vanni, E., Villanova, N., Melchionda, N., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50161 · Cited by 2,679
Inflammation, metaflammation and immunometabolic disorders
Hotamisligil, G. S. (2017) · Nature · doi:10.1038/nature21363 · Cited by 2,570
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
Henao-Mejia, J., Elinav, E., Jin, C., Hao, L., Mehal, W. Z., Strowig, T., Thaiss, C. A., Kau, A. L., Eisenbarth, S. C., Jurczak, M. J., et al. (2012) · Nature · doi:10.1038/nature10809 · Cited by 2,435
Estes, C., Razavi, H., Loomba, R., Younossi, Z., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29466 · Cited by 2,399
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
Di Micco, R., Krizhanovsky, V., Baker, D., & d’Adda di Fagagna, F. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00314-w · Cited by 2,277 · cited 4×
“Upon injury, the DDR forms a complex of DNA response factors, including phosphorylated H2AX (γH2AX), MDC1, 53BP1 and activated ataxia telangiectasia mutated (ATM), creating foci surrounding the damaged areas [30].”
BackgroundInfluentialPersistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion
Rodier, F., Coppé, J.-P., Patil, C. K., Hoeijmakers, W. A. M., Muñoz, D. P., Raza, S. R., Freund, A., Campeau, E., Davalos, A. R., & Campisi, J. (2009) · Nature Cell Biology · doi:10.1038/ncb1909 · Cited by 2,232
Senescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice
Chang, J., Wang, Y., Shao, L., Laberge, R.-M., Demaria, M., Campisi, J., Janakiraman, K., Sharpless, N. E., Ding, S., Feng, W., et al. (2016) · Nature Medicine · doi:10.1038/nm.4010 · Cited by 1,819 · cited 1×
“Some observations report an overexpression of anti-apoptotic BCL family proteins (BCL-XL, BCL-2, BCL-W) [31,32] and metabolic changes also include activation of β-galactosidase (senescence-associated β-galactosidase (SA-β-gal) [33] (Figure 2)).”
BackgroundSingh, S., Allen, A. M., Wang, Z., Prokop, L. J., Murad, M. H., & Loomba, R. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.04.014 · Cited by 1,748
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
Kang, T.-W., Yevsa, T., Woller, N., Hoenicke, L., Wuestefeld, T., Dauch, D., Hohmeyer, A., Gereke, M., Rudalska, R., Potapova, A., et al. (2011) · Nature · doi:10.1038/nature10599 · Cited by 1,621 · cited 1×
“In the context of mutations, senescence is considered protective since it prevents the unlimited proliferation and dissemination of potentially malignant cells [23].”
BackgroundSelf-citationLiver Macrophages in Tissue Homeostasis and Disease
Krenkel, O., & Tacke, F. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.11 · Cited by 1,424
Self-citationMitochondrial Dysfunction Induces Senescence with a Distinct Secretory Phenotype
Wiley, C. D., Velarde, M. C., Lecot, P., Liu, S., Sarnoski, E. A., Freund, A., Shirakawa, K., Lim, H. W., Davis, S. S., Ramanathan, A., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.11.011 · Cited by 1,275 · cited 1×
“Mitochondrial dysfunction may also lead to cellular senescence, and mitochondrial-dysfunction-associated senescence (MiDAS) is closely linked to alterations of cell metabolisms [25].”
BackgroundNonalcoholic Fatty Liver Disease 2020: The State of the Disease
Cotter, T. G., & Rinella, M. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.01.052 · Cited by 1,198
NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice
Mridha, A. R., Wree, A., Robertson, A. A. B., Yeh, M. M., Johnson, C. D., Van Rooyen, D. M., Haczeyni, F., Teoh, N. C.-H., Savard, C., Ioannou, G. N., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.01.022 · Cited by 1,110
Cellular senescence drives age-dependent hepatic steatosis
Ogrodnik, M., Miwa, S., Tchkonia, T., Tiniakos, D., Wilson, C. L., Lahat, A., Day, C. P., Burt, A., Palmer, A., Anstee, Q. M., et al. (2017) · Nature Communications · doi:10.1038/ncomms15691 · Cited by 1,044
Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL
Yosef, R., Pilpel, N., Tokarsky-Amiel, R., Biran, A., Ovadya, Y., Cohen, S., Vadai, E., Dassa, L., Shahar, E., Condiotti, R., et al. (2016) · Nature Communications · doi:10.1038/ncomms11190 · Cited by 1,032
The DNA damage response induces inflammation and senescence by inhibiting autophagy of GATA4.
Kang, C., Xu, Q., Martin, T. D., Li, M. Z., Demaria, M., Aron, L., Lu, T., Yankner, B. A., Campisi, J., & Elledge, S. J. (2015) · Science · doi:10.1126/science.aaa5612 · Cited by 982 · cited 1×
“GATA4 activates the transcription of effector molecules in an IL-1a-dependent manner [36].”
BackgroundLipotoxicity and the gut-liver axis in NASH pathogenesis
Marra, F., & Svegliati-Baroni, G. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.11.014 · Cited by 847 · cited 2×
“Disease progression in NAFLD is characterized by inflammation marking the transition to NASH and more severe stages of NAFLD [70,71].”
BackgroundRisk of hepatocellular cancer in patients with non-alcoholic fatty liver disease
Kanwal, F., Kramer, J. R., Mapakshi, S., Natarajan, Y., Chayanupatkul, M., Richardson, P. A., Li, L., Desiderio, R., Thrift, A. P., Asch, S. M., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.08.024 · Cited by 795 · cited 7×
“This culminates into a vicious cycle of accelerated fat accumulation, cell death and HCC development through ER stress, ROS activation and NAFLD progression [65].”
BackgroundInfluentialThe mitochondrial UPR: mechanisms, physiological functions and implications in ageing
Shpilka, T., & Haynes, C. M. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.110 · Cited by 714
Csak, T., Ganz, M., Pespisa, J., Kodys, K., Dolganiuc, A., & Szabo, G. (2011) · Hepatology · doi:10.1002/hep.24341 · Cited by 645
The role of ER stress in lipid metabolism and lipotoxicity
Han, J., & Kaufman, R. J. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r067595 · Cited by 645
Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum
Hardy, T., Oakley, F., Anstee, Q. M., & Day, C. P. (2016) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044224 · Cited by 611
Activation and Dysregulation of the Unfolded Protein Response in Nonalcoholic Fatty Liver Disease
Puri, P., Mirshahi, F., Cheung, O., Natarajan, R., Maher, J. W., Kellum, J. M., & Sanyal, A. J. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.10.039 · Cited by 597
Gaul, S., Leszczynska, A., Alegre, F., Kaufmann, B., Johnson, C. D., Adams, L. A., Wree, A., Damm, G., Seehofer, D., Calvente, C. J., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2020.07.041 · Cited by 552
Ahrens, M., Ammerpohl, O., von Schönfels, W., Kolarova, J., Bens, S., Itzel, T., Teufel, A., Herrmann, A., Brosch, M., Hinrichsen, H., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.07.004 · Cited by 546
Mitochondria as playmakers of apoptosis, autophagy and senescence
Abate, M., Festa, A., Falco, M., Lombardi, A., Luce, A., Grimaldi, A., Zappavigna, S., Sperlongano, P., Irace, C., Caraglia, M., et al. (2020) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2019.05.022 · Cited by 545
De novo NAD+ synthesis enhances mitochondrial function and improves health
Katsyuba, E., Mottis, A., Zietak, M., De Franco, F., van der Velpen, V., Gariani, K., Ryu, D., Cialabrini, L., Matilainen, O., Liscio, P., et al. (2018) · Nature · doi:10.1038/s41586-018-0645-6 · Cited by 430
TGFβ signaling plays a critical role in promoting alternative macrophage activation
Gong, D., Shi, W., Yi, S.-J., Chen, H., Groffen, J., & Heisterkamp, N. (2012) · BMC Immunology · doi:10.1186/1471-2172-13-31 · Cited by 420
Generation of Reactive Oxygen Species by Mitochondria
Hernansanz-Agustín, P., & Enríquez, J. A. (2021) · Antioxidants · doi:10.3390/antiox10030415 · Cited by 408
Quantitative identification of senescent cells in aging and disease
Biran, A., Zada, L., Abou Karam, P., Vadai, E., Roitman, L., Ovadya, Y., Porat, Z., & Krizhanovsky, V. (2017) · Aging Cell · doi:10.1111/acel.12592 · Cited by 402
Engelmann, C., Clària, J., Szabo, G., Bosch, J., & Bernardi, M. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.01.002 · Cited by 400
Self-citationRatziu, V., Sanyal, A., Harrison, S. A., Wong, V. W., Francque, S., Goodman, Z., Aithal, G. P., Kowdley, K. V., Seyedkazemi, S., Fischer, L., et al. (2020) · Hepatology · doi:10.1002/hep.31108 · Cited by 378
Self-citationYounossi, Z., & Henry, L. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.03.005 · Cited by 334 · cited 1×
“Although cardiovascular events and malignancies represent the most frequent causes of death within the NAFLD cohort, liver-related complications and deaths are still far higher than in the normal population (Figure 1) [9].”
BackgroundHepatocyte senescence predicts progression in non-alcohol-related fatty liver disease
Aravinthan, A., Scarpini, C., Tachtatzis, P., Verma, S., Penrhyn-Lowe, S., Harvey, R., Davies, S. E., Allison, M., Coleman, N., & Alexander, G. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.10.031 · Cited by 326
An, P., Wei, L.-L., Zhao, S., Sverdlov, D. Y., Vaid, K. A., Miyamoto, M., Kuramitsu, K., Lai, M., & Popov, Y. V. (2020) · Nature Communications · doi:10.1038/s41467-020-16092-0 · Cited by 319 · cited 1×
“Mitochondria-derived DAMPs (mito-DAMPs) released by hepatocytes after mitochondrial injury trigger maturation of stellate cells and circulating levels of mito-DAMPs are significantly increased in NASH [87].”
BackgroundHaldar, D., Kern, B., Hodson, J., Armstrong, M. J., Adam, R., Berlakovich, G., Fritz, J., Feurstein, B., Popp, W., Karam, V., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.04.011 · Cited by 313
Macrophage MerTK Promotes Liver Fibrosis in Nonalcoholic Steatohepatitis
Cai, B., Dongiovanni, P., Corey, K. E., Wang, X., Shmarakov, I. O., Zheng, Z., Kasikara, C., Davra, V., Meroni, M., Chung, R. T., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2019.11.013 · Cited by 266 · cited 1×
“The effect of TGF-β1 might be more diverse as other studies showed that this cytokine not only spreads senescence [26] but also activates alternative-type macrophages [78] and hepatic stellate cells [79] in a paracrine manner along with other components of the SASP.”
BackgroundCell fusion induced by ERVWE1 or measles virus causes cellular senescence
Chuprin, A., Gal, H., Biron-Shental, T., Biran, A., Amiel, A., Rozenblatt, S., & Krizhanovsky, V. (2013) · Genes & Development · doi:10.1101/gad.227512.113 · Cited by 262 · cited 1×
“In addition, senescence is an essential process during maturation that ensures coordinated and controlled growth [24].”
BackgroundBird, T. G., Müller, M., Boulter, L., Vincent, D. F., Ridgway, R. A., Lopez-Guadamillas, E., Lu, W.-Y., Jamieson, T., Govaere, O., Campbell, A. D., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aan1230 · Cited by 261
Weiskirchen, R., & Tacke, F. (2014) · PubMed · doi:10.3978/j.issn.2304-3881.2014.11.03 · Cited by 256
Self-citationYounes, R., & Bugianesi, E. (2019) · Seminars in Liver Disease · doi:10.1055/s-0038-1677517 · Cited by 235
Guy, C. D., Suzuki, A., Zdanowicz, M., Abdelmalek, M. F., Burchette, J., Unalp, A., & Diehl, A. M. (2012) · Hepatology · doi:10.1002/hep.25559 · Cited by 218
Hardy, T., Zeybel, M., Day, C. P., Dipper, C., Masson, S., McPherson, S., Henderson, E., Tiniakos, D., White, S., French, J., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-311526 · Cited by 216 · cited 2×
“As the consequence of all these positive results, plasma DNA methylation was proposed as a potential biomarker for NASH-related fibrosis [47].”
BackgroundMethodPapatheodoridi, A., Chrysavgis, L., Koutsilieris, M., & Chatzigeorgiou, A. (2020) · Hepatology · doi:10.1002/hep.30834 · Cited by 209
Younes, R., Govaere, O., Petta, S., Miele, L., Tiniakos, D., Burt, A., David, E., Vecchio, F. M., Maggioni, M., Cabibi, D., et al. (2022) · Gut · doi:10.1136/gutjnl-2020-322564 · Cited by 205
Calcium channel ITPR2 and mitochondria–ER contacts promote cellular senescence and aging
Ziegler, D. V., Vindrieux, D., Goehrig, D., Jaber, S., Collin, G., Griveau, A., Wiel, C., Bendridi, N., Djebali, S., Farfariello, V., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-20993-z · Cited by 194
Negi, C. K., Babica, P., Bajard, L., Bienertova-Vasku, J., & Tarantino, G. (2022) · Metabolism · doi:10.1016/j.metabol.2021.154925 · Cited by 190
Generation of telomere-length heterogeneity in Saccharomyces cerevisiae.
Shampay, J., & Blackburn, E. H. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.2.534 · Cited by 170
IGF-I induces senescence of hepatic stellate cells and limits fibrosis in a p53-dependent manner
Nishizawa, H., Iguchi, G., Fukuoka, H., Takahashi, M., Suda, K., Bando, H., Matsumoto, R., Yoshida, K., Odake, Y., Ogawa, W., et al. (2016) · Scientific Reports · doi:10.1038/srep34605 · Cited by 164 · cited 1×
“[90] Mice (C57BL/6; db/db) MCD diet 2 IGF-1 prevents from fibrosis in NASH by inducing cellular senescence to HSC through p53”
BackgroundParacrine cellular senescence exacerbates biliary injury and impairs regeneration
Ferreira-Gonzalez, S., Lu, W.-Y., Raven, A., Dwyer, B., Man, T. Y., O’Duibhir, E., Lewis, P. J. S., Campana, L., Kendall, T. J., Bird, T. G., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03299-5 · Cited by 161
Wang, L., Liu, X., Nie, J., Zhang, J., Kimball, S. R., Zhang, H., Zhang, W. J., Jefferson, L. S., Cheng, Z., Ji, Q., et al. (2015) · Hepatology · doi:10.1002/hep.27420 · Cited by 150
Mossanen, J. C., Kohlhepp, M. S., Wehr, A., Krenkel, O., Liepelt, A., Roeth, A. A., Möckel, D., Heymann, F., Lammers, T., Gaßler, N., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.01.247 · Cited by 133
Self-citationTomita, K., Teratani, T., Suzuki, T., Oshikawa, T., Yokoyama, H., Shimamura, K., Nishiyama, K., Mataki, N., Irie, R., Minamino, T., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.05.013 · Cited by 127
Cenicriviroc for the treatment of non-alcoholic steatohepatitis and liver fibrosis
Tacke, F. (2018) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2018.1442436 · Cited by 121
Self-citationApoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression
Farrell, G. C., Larter, C. Z., Hou, J. Y., Zhang, R. H., Yeh, M. M., Williams, J., Dela Peňa, A., Francisco, R., Osvath, S. R., Brooling, J., et al. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.05785.x · Cited by 120
Loss of mitochondrial protease ClpP protects mice from diet‐induced obesity and insulin resistance
Bhaskaran, S., Pharaoh, G. A., Ranjit, R., Murphy, A., Matsuzaki, S., Nair, B. C., Forbes, B., Gispert, S., Auburger, G. W. J., Humphries, K. M., et al. (2018) · EMBO Reports · doi:10.15252/embr.201745009 · Cited by 111
Expression of p53, Bax and Bcl-2 proteins in hepatocytes in non-alcoholic fatty liver disease
Panasiuk, A. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i38.6198 · Cited by 108
Xu, Y., Zhu, Y., Hu, S., Xu, Y., Stroup, D., Pan, X., Bawa, F. N. C., Chen, S., Gopoju, R., Yin, L., et al. (2020) · Hepatology · doi:10.1002/hep.31604 · Cited by 96
Daugherity, E. K., Balmus, G., Saei, A. A., Moore, E. S., Abdallah, D. S. A., Rogers, A. B., Weiss, R. S., & Maurer, K. J. (2012) · Cell Cycle · doi:10.4161/cc.20259 · Cited by 92
Li, D., Sun, S.-J., Fu, J., Ouyang, S., Zhao, Q.-J., Su, L., Ji, Q.-X., Sun, D.-Y., Zhu, J., Zhang, G., et al. (2021) · Theranostics · doi:10.7150/thno.53652 · Cited by 90
The role of mitochondria dysfunction and hepatic senescence in NAFLD development and progression
Dabravolski, S. A., Bezsonov, E. E., & Orekhov, A. N. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112041 · Cited by 87
Aravinthan, A. D., Mells, G. F., Allison, M. E., Leathart, J. B. S., Kotronen, A., Yki‐Järvinen, H., Daly, A. K., Day, C. P., Anstee, Q. M., & Alexander, G. (2014) · Cell Cycle · doi:10.4161/cc.28471 · Cited by 74
Pirola, C. J., Garaycoechea, M. E., Flichman, D., Castaño, G. O., & Sookoian, S. C. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13147 · Cited by 73
Zhang, X., Zhou, D., Strakovsky, R. S., Zhang, Y., & Pan, Y. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00032.2011 · Cited by 69
Hotta, K., Kitamoto, A., Kitamoto, T., Ogawa, Y., Honda, Y., Kessoku, T., Yoneda, M., Imajo, K., Tomeno, W., Saito, S., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-31886-5 · Cited by 67
Thyroid hormone-mediated autophagy and mitochondrial turnover in NAFLD
Sinha, R. A., & Yen, P. M. (2016) · Cell & Bioscience · doi:10.1186/s13578-016-0113-7 · Cited by 67
Cellular Senescence in Liver Disease and Regeneration
Ferreira-González, S., Rodrigo‐Torres, D., Gadd, V. L., & Forbes, S. J. (2021) · Seminars in Liver Disease · doi:10.1055/s-0040-1722262 · Cited by 66
Wan, J., Wu, X., Chen, H., Xia, X., Song, X., Chen, S., Lu, X., Jin, J., Su, Q., Cai, D., et al. (2020) · Aging Cell · doi:10.1111/acel.13238 · Cited by 64
Heat shock protein 72 regulates hepatic lipid accumulation
Archer, A. E., Rogers, R. S., Schulze, A. T. V., Wheatley, J. L., Morris, E. M., McCoin, C. S., Thyfault, J. P., & Geiger, P. C. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00073.2018 · Cited by 58
Discordant hepatic fatty acid oxidation and triglyceride hydrolysis leads to liver disease
Alpergin, E. S. S., Choi, J., & Wolfgang, M. J. (2021) · JCI Insight · doi:10.1172/jci.insight.135626 · Cited by 56
Xu, T., Ni, M.-M., Xingli, Li, X., Meng, X., Huang, C., & Li, J. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.11.010 · Cited by 54
Telomere Dysfunction in Nonalcoholic Fatty Liver Disease and Cryptogenic Cirrhosis
Laish, I., Mannasse-Green, B., Hadary, R., Biron-Shental, T., Konikoff, F. M., Amiel, A., & Kitay-Cohen, Y. (2016) · Cytogenetic and Genome Research · doi:10.1159/000454654 · Cited by 49
Han, X., Bao, X., Lou, Q., Xie, X. M., Zhang, M., Zhou, S., Guo, H., Jiang, G., & Shi, Q. (2019) · PeerJ · doi:10.7717/peerj.7568 · Cited by 45
Kondo, Y., Masutomi, H., Noda, Y., Ozawa, Y., Takahashi, K., Handa, S., Maruyama, N., Shimizu, T., & Ishigami, A. (2014) · FEBS Open Bio · doi:10.1016/j.fob.2014.05.003 · Cited by 44
Johnson, N. D., Wu, X., Still, C. D., Chu, X., Petrick, A. T., Gerhard, G. S., Conneely, K. N., & DiStefano, J. K. (2021) · Clinical Epigenetics · doi:10.1186/s13148-021-01129-y · Cited by 43
Ping, F., Li, Z., Lv, K., Zhou, M., Dong, Y., Sun, Q., & Li, Y. (2016) · Journal of Diabetes Investigation · doi:10.1111/jdi.12555 · Cited by 43
Recombinant Alkaline Phosphatase Prevents Acute on Chronic Liver Failure
Engelmann, C., Adebayo, D., Oria, M., De Chiara, F., Novelli, S., Habtesion, A., Davies, N., Andreola, F., & Jalan, R. (2020) · Scientific Reports · doi:10.1038/s41598-019-57284-z · Cited by 41
Self-citationAkazawa, Y., Nakashima, R., Matsuda, K., Okamaoto, K., Hirano, R., Kawasaki, H., Miuma, S., Miyaaki, H., Malhi, H., Abiru, S., et al. (2019) · Modern Pathology · doi:10.1038/s41379-019-0218-8 · Cited by 38
Lohr, K., Pachl, F., Gholami, A. M., Geillinger, K. E., Daniel, H., Küster, B., & Klingenspor, M. (2016) · Physiological Reports · doi:10.14814/phy2.12988 · Cited by 36
Thorin‐Trescases, N., Labbé, P., Mury, P., Lambert, M., & Thorin, É. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212232 · Cited by 31
Kondo, Y., Hasegawa, G., Okada, H., Senmaru, T., Fukui, M., Nakamura, N., Sawada, M., Kitawaki, J., Okanoue, T., Kishimoto, Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065698 · Cited by 30
Hsieh, J., Li, S., Tsai, W.-C., Liu, J., Lin, C., Liu, G., & Hung, H. (2015) · Oncotarget · doi:10.18632/oncotarget.3907 · Cited by 28
Targeting Ca2+ Signaling in the Initiation, Promotion and Progression of Hepatocellular Carcinoma
Ali, E. S., Rychkov, G. Y., & Barritt, G. J. (2020) · Cancers · doi:10.3390/cancers12102755 · Cited by 19
Qin, Y., Duan, L., He, Y., Yuan, C., Wang, T., Yuan, D., Zhang, C., & Liu, C. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202000383 · Cited by 14
Engelmann, C., Andreola, F., Habtesion, A., Novelli, S., Kerbert, A. J. C., Davies, N. A., Ferreira-González, S., Forbes, S. J., Berg, T., & Jalan, R. (2020) · Journal of Hepatology · doi:10.1016/s0168-8278(20)30610-3 · Cited by 2
Self-citation
Cited by
Peiseler, M., Schwabe, R., Hampe, J., Kubes, P., Heikenwälder, M., & Tacke, F. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.06.012 · Cited by 564
Self-citationAn integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH
Tacke, F., Puengel, T., Loomba, R., & Friedman, S. L. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.03.038 · Cited by 321
Self-citationUnderstanding the cellular interactome of non-alcoholic fatty liver disease
Wallace, S. J., Tacke, F., Schwabe, R. F., & Henderson, N. C. (2022) · JHEP Reports · doi:10.1016/j.jhepr.2022.100524 · Cited by 116
Self-citationThe Multifaceted Roles of Macrophages in NAFLD Pathogenesis
Vonderlin, J., Chavakis, T., Sieweke, M., & Tacke, F. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.03.002 · Cited by 96
“In NASH, a proinflammatory hepatic microenvironment stimulates fibrogenic processes leading to liver fibrosis and, eventually, cirrhosis.(3) The only curative therapy for end-stage liver disease and the early stages of hepatocellular carcinoma is liver transplantation.”
BackgroundSelf-citationZhang, C.-Y., Tan, X., Yang, H., Jin, L., Hong, J., Zhou, Y., & Huang, X. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158267 · Cited by 98
Metadata
- Authors
- Engelmann, C., & Tacke, F.
- Affiliations
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE)
- Charité – Universitätsmedizin Berlin (DE)
- Corresponding author
- Engelmann, Cornelius
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-01-07
- Volume
- 23
- Issue
- 2
- Pages
- 652
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8775400
- OpenAlex
- W4205372104
- Cited by
- 61
- References
- 90
- Citations by year
- 2026: 13 · 2025: 12 · 2024: 14 · 2023: 10 · 2022: 12
- FWCI
- 1.91
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Refubium (Universitätsbibliothek der Freien Universität Berlin) (submittedVersion, cc-by)
- Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver (cc-by)
- Funders
- Bristol-Myers Squibb
- Gilead Sciences
- CSL Behring
- Berlin Institute of Health
- Allergan
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- cellular senescence, non-alcoholic fatty liver disease, hepatocyte senescence, hepatic stellate cells, liver fibrosis, senescence-associated inflammation, extracellular matrix deposition, therapeutic target
- MeSH terms
- Extracellular Matrix, Humans, Cellular Senescence, Disease Progression, Hepatocytes, Hepatic Stellate Cells, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.